Am. J. Respir. Cell Mol. Biol.,
Volume 19, Number 1, July, 1998 129-142
Prolonged Cell-cycle Arrest Associated with Altered cdc2 Kinase in
Monocrotaline Pyrrole-treated Pulmonary Artery Endothelial Cells
Heath C.
Thomas,*
Michael W.
Lamé,
Dexter
Morin,
Dennis W.
Wilson,
and
H. J.
Segall
Departments of Veterinary: Pathology, Microbiology and Immunology, and Molecular Biosciences, University of
California at Davis, Davis, California
Monocrotaline pyrrole (MCTP), a metabolite of the pyrrolizidine alkaloid monocrotaline, is thought to initiate damage to pulmonary endothelial cells resulting in delayed but progressive pulmonary interstitial
edema, vascular wall remodeling, and increasing pulmonary hypertension. MCTP was previously shown
to inhibit pulmonary endothelial cell proliferation and cause cell-cycle arrest in vitro. To determine the
persistence of arrest and better characterize the cell-cycle stage at which it occurs, bovine pulmonary artery endothelial cells (BPAEC) under differing growth conditions were exposed to low (5 µg/ml) or high
(34.5 µg/ml) concentrations of MCTP for varying times. Flow cytometric cell-cycle analysis was coupled with Western blot and biochemical analysis of cdc2 kinase and measurements of cell size. MCTP treatment induced a G2 + M phase arrest in 48-h exposed confluent BPAEC that persisted for at least 28 d and
was associated with continued cellular enlargement. A short-duration MCTP exposure of confluent (low
and high concentration) and log phase (high concentration) BPAEC caused persistent cell-cycle arrest for
1 wk, whereas a low-concentration exposure in log phase cells resulted in cell-cycle arrest with reversal 96 h after exposure. Western blot examination revealed that by 24 h of MCTP exposure, the phosphorylation
state of cdc2 was consistent with the inactive form of the kinase (confirmed by biochemical assay); this alteration persisted through at least 96 h of exposure. We conclude that MCTP induces a progressive irreversible endothelial cell dysfunction leading to inactivation of cdc2 kinase and irreversible cell-cycle arrest
at the G2 checkpoint.
*
Present address: Department of Toxicology, SmithKline Beecham Pharmaceuticals, 709 Swedeland Rd., P.O. Box 1539, King of Prussia, PA
19406.
*
%BAD is defined as the proportion of events in a histogram between
the lowest G1 and the highest G2 that are due to debris and aggregates as
modeled by the analysis program (MULTICYCLE manual).